Pharmacokinetics studies of 4'-cyano-2'-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats.
Mai HashimotoKazuaki TaguchiTakako IshiguroSatoru KohgoShuhei ImotoKeishi YamasakiHiroaki MitsuyaMasaki OtagiriPublished in: The Journal of pharmacy and pharmacology (2018)
The data generated in this study provide support for the clinical development of CdG for use in the treatment of HBV.